|
1
|
Yang F, Wang J, Hou J, Guo H and Liu C:
Bone regeneration using cell-mediated responsive degradable
PEG-based scaffolds incorporating with rhBMP-2. Biomaterials.
34:1514–1528. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ho-Shui-Ling A, Bolander J, Rustom LE,
Johnson AW, Luyten FP and Picart C: Bone regeneration strategies:
Engineered scaffolds, bioactive molecules and stem cells current
stage and future perspectives. Biomaterials. 180:143–162. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baraban SC: Neuropeptide Y and limbic
seizures. Rev Neurosci. 9:117–128. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Silva AP, Cavadas C and Grouzmann E:
Neuropeptide Y and its receptors as potential therapeutic drug
targets. Clin Chim Acta. 326:3–25. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baldock PA, Lin S, Zhang L, Karl T, Shi Y,
Driessler F, Zengin A, Hörmer B, Lee NJ, Wong IP, et al:
Neuropeptide Y attenuates stress-induced bone loss through
suppression of noradrenaline circuits. J Bone Miner Res.
29:2238–2249. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kuo LE, Kitlinska JB, Tilan JU, Li L,
Baker SB, Johnson MD, Lee EW, Burnett MS, Fricke ST, Kvetnansky R,
et al: Neuropeptide Y acts directly in the periphery on fat tissue
and mediates stress-induced obesity and metabolic syndrome. Nat
Med. 13:803–811. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baldock PA, Allison SJ, Lundberg P, Lee
NJ, Slack K, Lin EJD, Enriquez RF, McDonald MM, Zhang L, During MJ,
et al: Novel role of Y1 receptors in the coordinated regulation of
bone and energy homeostasis. J Biol Chem. 282:19092–19102. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang K, Guan H, Arany E, Hill DJ and Cao
X: Neuropeptide Y is produced in visceral adipose tissue and
promotes proliferation of adipocyte precursor cells via the Y1
receptor. FASEB J. 22:2452–2464. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Khor EC and Baldock P: The NPY system and
its neural and neuroendocrine regulation of bone. Curr Osteoporos
Rep. 10:160–168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Horsnell H and Baldock PA: Osteoblastic
actions of the neuropeptide Y system to regulate bone and energy
homeostasis. Curr Osteoporos Rep. 14:26–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin S, Boey D and Herzog H: NPY and Y
receptors: Lessons from transgenic and knockout models.
Neuropeptides. 38:189–200. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Allison SJ, Baldock PA and Herzog H: The
control of bone remodeling by neuropeptide Y receptors. Peptides.
28:320–325. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yahara M, Tei K and Tamura M: Inhibition
of neuropeptide Y Y1 receptor induces osteoblast differentiation in
MC3T3E1 cells. Mol Med Rep. 16:2779–2784. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karsenty G: Transcriptional control of
skeletogenesis. Annu Rev Genomics Hum Genet. 9:183–196. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Igwe JC, Jiang X, Paic F, Ma L, Adams DJ,
Baldock PA, Pilbeam CC and Kalajzic I: Neuropeptide Y is expressed
by osteocytes and can inhibit osteoblastic activity. J Cell
Biochem. 108:621–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen J, He G, Wang Y and Cai D:
MicroRNA-223 promotes osteoblast differentiation of MC3T3-E1 cells
by targeting histone deacetylase 2. Int J Mol Med. 43:1513–1521.
2019.PubMed/NCBI
|
|
19
|
Han J, Zuo J, Zhu D and Gao C: The
correlation between SNPs within the gene of adrenergic receptor and
neuropeptide Y and risk of cervical vertigo. J Clin Lab Anal.
32:e223662018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li L, Sapkota M, Gao M, Choi H and Soh Y:
Macrolactin F inhibits RANKL-mediated osteoclastogenesis by
suppressing Akt, MAPK and NFATc1 pathways and promotes
osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling
pathway. Eur J Pharmacol. 815:202–209. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tatemoto K, Carlquist M and Mutt V:
Neuropeptide Y-a novel brain peptide with structural similarities
to peptide YY and pancreatic polypeptide. Nature. 296:659–660.
1982. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Allen JM, Adrian TE, Tatemoto K, Polak JM,
Hughes J and Bloom SR: Two novel related peptides, neuropeptide Y
(NPY) and peptide YY (PYY) inhibit the contraction of the
electrically stimulated mouse vas deferens. Neuropeptides. 3:71–77.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baldock PA, Sainsbury A, Allison S, Lin
EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H and Gardiner
EM: Hypothalamic control of bone formation: distinct actions of
leptin and y2 receptor pathways. J Bone Miner Res. 20:1851–1857.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Moon JS, Kim SH, Oh SH, Jeong YW, Kang JH,
Park JC, Son HJ, Bae S, Park BI, Kim MS, et al: Relaxin augments
BMP-2-induced osteoblast differentiation and bone formation. J Bone
Miner Res. 29:1586–1596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hecht J, Seitz V, Urban M, Wagner F,
Robinson PN, Stiege A, Dieterich C, Kornak U, Wilkening U, Brieske
N, et al: Detection of novel skeletogenesis target genes by
comprehensive analysis of a Runx2(−/-) mouse model. Gene Expr
Patterns. 7:102–112. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao ZS, Hjelmeland AB and Quarles LD:
Selective deficiency of the ‘bone-related’ Runx2-II unexpectedly
preserves osteoblast-mediated skeletogenesis. J Biol Chem.
279:20307–20313. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakashima K, Zhou X, Kunkel G, Zhang Z,
Deng JM, Behringer RR and de Crombrugghe B: The novel zinc
finger-containing transcription factor osterix is required for
osteoblast differentiation and bone formation. Cell. 108:17–29.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang X, Yang Y, Sun BF, Chen YS, Xu JW,
Lai WY, Li A, Wang X, Bhattarai DP, Xiaot W, et al:
5-methylcytosine promotes mRNA export-NSUN2 as the
methyltransferase and ALYREF as an m5C reader. Cell Res.
27:606–625. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu J, Fang H, Chi Z, Wu Z, Wei D, Mo D,
Niu K, Balajee AS, Hei TK, Nie L and Zhao Y: XPD localizes in
mitochondria and protects the mitochondrial genome from oxidative
DNA damage. Nucleic Acids Res. 43:5476–5488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao C, Peng S, Feng P and Shuai C: Bone
biomaterials and interactions with stem cells. Bone Res.
5:170592017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shuai C, Xu Y, Feng P, Wang G, Xiong S and
Peng S: Antibacterial polymer scaffold based on mesoporous
bioactive glass loaded with in situ grown silver. Chemical
Engineering J. 374:304–315. 2019. View Article : Google Scholar
|
|
32
|
Yang Y, Zan J, Yang W, Qi F, He C, Huang
S, Peng S and Shuai C: Metal organic frameworks as a compatible
reinforcement in a biopolymer bone scaffold. Materials Chem Front.
4:973–984. 2020. View Article : Google Scholar
|
